APRIL 2021 Derek Bagley Proof-of-Concept Study Shows CGM Benefit in Patients with COVID-19 A proof-of-concept study recently published in Diabetes Care shows how inpatient diabetes technology is advancing and can provide meaningful improvements in care today and in a post-pandemic world. The research team, led by Francisco J. Pasquel, MD, MPH, assistant professor of medicine in the Division of Endocrinology at Emory …
April 20, 2021
2021 Medical Design Excellence Awards Finalists
APRIL 12, 2021 2021 Medical Design Excellence Awards Finalists The Medical Design Excellence Awards competition is the medical technology industry’s premier awards program. Since 1998, the MDEAs have recognized achievements in medical product design and engineering that improve the quality of healthcare delivery and accessibility. Each year, a panel of jurors comprised of designers, engineers, and clinicians awards bronze, silver, …
Insulin Dosing Software Appears to Reduce Glycemic Events
APRIL 2021 Derek Bagley Insulin Dosing Software Appears to Reduce Glycemic Events Recently, Metro Health – University of Michigan Health, an affiliate of University of Michigan Health, announced that it reduced incidence of hypoglycemia by more than 54% and experienced a 40% decline in hyperglycemia since implementing personalized insulin dosing software. Glytec is marketing the software as the eGlycemic Management …
June 15, 2020
Onduo, Medtronic, Abbott, Glytec present diabetes management study data at ADA 2020 virtual conference
JUNE 2020 DAVE MUOIO Onduo, Medtronic, Abbott, Glytec present diabetes management study data at ADA 2020 virtual conference From virtual management programs to hybrid closed loop systems, diabetes management companies put the spotlight on improved blood glucose management and positive clinical outcomes. The American Diabetes Association’s 80th Scientific Sessions kicked off this weekend, and a handful of diabetes management device-makers …
May 16, 2019
Glytec Awarded Patent Allowance for Virtual Insulin Titration in Concert with CGM, Smart Pens and Other Diabetes Technologies
The company’s growing intellectual property portfolio attests to its leadership position in diabetes medication optimization in an era of data-driven care.
Glytec, the pioneer of digital therapeutics, has been awarded another patent allowance by the United States Patent and Trademark Office (USPTO). The latest allowance references interactions between the company’s software-as-a-medical-device platform for insulin titration and multiple connected diabetes technologies, including continuous glucose monitoring (CGM) systems, smart insulin pens and insulin pumps.
November 29, 2017
Glytec Integrates With Onduo Virtual Diabetes Clinic
The integrated solution will launch in pilot programs with select U.S. providers and payers early 2018.
Glytec is pleased to announce its Glucommander™ Outpatient will be integrated with Onduo’s virtual diabetes clinic to help people with type 2 diabetes more easily manage insulin therapy and achieve their glucose targets. Onduo, a joint venture of Sanofi and Verily (an Alphabet company), is developing a virtual platform that integrates hardware, such as wirelessly-connected continuous glucose monitors, software and personalized support from healthcare experts to help people manage their type 2 diabetes. The integrated solution will launch in pilot programs with select U.S. providers and payers early 2018.
April 10, 2017
Advancements in Diabetes Treatment to Watch
The healthcare industry continues to focus efforts on treatments that work better, and ideally are less expensive and less invasive for patients.
Diabetes therapy management software with decision support for dosing and titration is the final piece of the therapeutic puzzle. In concert with data made available through CGM and cBGM, this software can help providers properly dose and titrate diabetes medications, especially insulin, and choose which diabetes medications may work best for each patient. Diabetes therapy management software, in its earliest form, was launched by Glytec in 2006.
